Silviu Itescu
Founder at MESOBLAST LIMITED
Net worth: 51 M $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Eric Rose | M | 73 | 11 years | |
Paul Hughes | M | - | 5 years | |
Jane Bell | F | - | 2 years | |
Andrew Chaponnel | M | - | 12 years | |
Joseph Swedish | M | 72 | 6 years | |
Michael Schuster | M | - | 20 years | |
Jay L. Eastman | M | - |
Columbia University Medical Center
| - |
Paul Simmons | M | - | 13 years | |
Geraldine Storton | F | - | 9 years | |
Philip Krause | M | - | 2 years | |
William Burns | M | 76 | 10 years | |
Philip Facchina | M | 62 | 3 years | |
John Mack | M | 79 |
Columbia University Medical Center
| - |
Richard L. Berkowitz | M | - |
Columbia University Medical Center
| - |
Leonard Francis West | M | 72 |
Mesoblast UK Ltd.
Mesoblast UK Ltd. Miscellaneous Commercial ServicesCommercial Services Mesoblast UK Ltd. engages in the provision of support services for the development of regenerative medicine products. The company was founded on April 7, 2011 and is headquartered in London, the United Kingdom. | - |
Beth Schrope | F | - |
Columbia University Medical Center
| - |
Joshua Sonett | M | - |
Columbia University Medical Center
| - |
Michael Pitman | M | - |
Columbia University Medical Center
| - |
Naseem Zojwalla | M | 51 |
Columbia University Medical Center
| - |
Niva Sivakumar | F | - | 10 years | |
Joseph Jurcic | M | - |
Columbia University Medical Center
| - |
Gary K. Schwartz | M | - |
Columbia University Medical Center
| - |
Michael Anthony Sampson | M | 72 |
Mesoblast UK Ltd.
Mesoblast UK Ltd. Miscellaneous Commercial ServicesCommercial Services Mesoblast UK Ltd. engages in the provision of support services for the development of regenerative medicine products. The company was founded on April 7, 2011 and is headquartered in London, the United Kingdom. | - |
Jonathan Leff | M | 55 |
Columbia University Medical Center
| - |
Dinakar Singh | M | 55 |
Columbia University Medical Center
| - |
Michael Weiss | M | 73 |
Columbia University Medical Center
| 37 years |
David J. Lederer | M | - |
Columbia University Medical Center
| 16 years |
Darryl C. de Vivo | M | - |
Columbia University Medical Center
| - |
Stephan Anthony Mayer | M | - |
Columbia University Medical Center
| - |
Noam Gottesman | M | 62 |
Columbia University Medical Center
| - |
Peter Howard | M | - | 13 years | |
Dagmar Rosa-Bjorkeson | F | 60 | 4 years | |
Peter John Sacripanti | M | 68 |
Columbia University Medical Center
| - |
Andrew R. Marks | M | - |
Columbia University Medical Center
| - |
David Ho | M | 71 |
Columbia University Medical Center
| - |
Jonathan Symonds | M | 66 | - | |
Martin Leon | M | - |
Columbia University Medical Center
| 14 years |
Claudia A. Chiriboga | F | - |
Columbia University Medical Center
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Charlie Harrison | M | - | 9 years | |
Michael Spooner | M | - | 19 years | |
Donna Skerrett | M | - |
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | 15 years |
Jennifer Pilcher | F | - | 7 years | |
Brian Jamieson | M | 79 | 12 years | |
Paul Rennie | M | - | - | |
James Ryaby | M | 65 | 2 years | |
Suzanne Lipe | M | - | - | |
Susan MacLeman | F | - | 5 years | |
Shawn Tomasello | F | 65 | 4 years | |
Fred Grossman | M | 62 |
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | 3 years |
Donal O'Dwyer | M | 71 | 18 years | |
Ben-Zion Weiner | M | 80 | 6 years | |
Lee Golden | M | 56 | 5 years | |
Thomas Hallam | M | 50 | 2 years | |
Schond Greenway | M | 52 | 5 years | |
Scott Terrillion | M | 61 |
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | 2 years |
J. Buchi | M | 69 | 2 years | |
Paul Hodgkinson | M | - | 4 years | |
Michael Warman | M | - | - | |
Kenneth B. Newman | M | 66 |
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | 1 years |
Julie Meldrum | F | - | - | |
Graeme Roy Kaufman | M | 74 | - | |
Byron T. McAllister | M | - | 5 years | |
Joshua Muntner | M | 55 | 3 years | |
Sean Ryder | M | 54 | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
Australia | 39 | 60.94% |
United States | 25 | 39.06% |
United Kingdom | 2 | 3.13% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Silviu Itescu
- Personal Network